We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Systematic reviews and meta-analyses of randomised controlled trials have highlighted a dose-dependent increased risk of atrial fibrillation in patients with established cardiovascular diseases or cardiovascular risk factors treated with omega-3-acid ethyl ester medicines compared to placebo.
Data and analysis of cardiovascular disease (CVD) prevalence, variation, treatment and outcomes in the Corby CCG area.
Data and analysis of cardiovascular disease (CVD) prevalence, variation, treatment and outcomes in the Haringey CCG area.
You may need to send DVLA a form if you've had a heart attack (myocardial infarction) or heart, cardiac or coronary angioplasty.
First published during the 2022 to 2024 Sunak Conservative government
Update of information on diabetes in the cardiovascular disease (CVD) profiles.
You may need to tell DVLA if you have a coronary artery bypass or disease - if you do, download the correct form to let them know
Data and analysis of cardiovascular disease (CVD) prevalence, variation, treatment and outcomes in the Kernow CCG area.
Data and analysis of cardiovascular disease (CVD) prevalence, variation, treatment and outcomes in the Castle Point and Rochford CCG area.
Data and analysis of cardiovascular disease (CVD) prevalence, variation, treatment and outcomes in the Merton CCG area.
Data and analysis of cardiovascular disease (CVD) prevalence, variation, treatment and outcomes in the Knowsley CCG area.
Data and analysis of cardiovascular disease (CVD) prevalence, variation, treatment and outcomes in the Hammersmith and Fulham CCG area.
Eric Schmidt and Ken Griffin are being announced as the first members of a new consortium that will shape the future of the best-in-class UK Biobank.
Data and analysis of cardiovascular disease (CVD) prevalence, variation, treatment and outcomes in the Central London (Westminster) CCG area.
This is a systematic review and meta-analysis
Data and analysis of cardiovascular disease (CVD) prevalence, variation, treatment and outcomes in the Crawley CCG area.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).